Dr. Carrie L. Langstraat, MD

Dr. Langstraat practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Langstraat's NPI, 1184707572, was assigned on October 23, 2006. Dr. Langstraat graduated from University Of Minnesota Medical School in 2003. Dr. Langstraat holds Minnesota license 103795.

Dr. Langstraat's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Langstraat's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Langstraat is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Langstraat to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Langstraat's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langstraat practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Langstraat's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Langstraat is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Langstraat's licenses on file in 15 states: Minnesota, Arizona, Iowa, Montana, Connecticut, Illinois, Michigan, North Dakota, Wisconsin, Florida, Georgia, Missouri, New Hampshire, Alaska and Kentucky.

Dmand AI lists hysterectomy among the conditions Dr. Langstraat treats.

CMS data shows 66 Medicare services from Dr. Langstraat across 5 procedure codes in 2024, for 66 Medicare patients. Medicare paid $14,941 for them.

CMS counts 66 Medicare patients who saw Dr. Langstraat in 2024. The largest group is 65 to 74, with 31 patients. 73% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langstraat's median patient age at 66, with 100% women.

In 2024, Dr. Langstraat wrote 17 Medicare Part D claims. 88% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $46 in total drug cost. In 2021, CMS named 44 claims across 3 drugs.

Dr. Langstraat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Langstraat as offering telehealth. CMS counts 27 procedures of removal of the uterus by Dr. Langstraat, more than 96% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 114 papers to Dr. Langstraat, published from 2011 to 2025. 2020 was the busiest year, with 19. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Endometrial Neoplasms. Dr. Langstraat has published most often in Gynecol Oncol. Dr. Langstraat's most frequent co-authors are Amanika Kumar, MD, William A. Cliby, MD and Andrea Mariani, MD.

Dmand AI links Dr. Langstraat to 2 clinical trials. Conditions studied include Fallopian Tube Diseases, Ovarian Neoplasms and Fallopian Tube Neoplasms.

CMS Open Payments shows 21 general payments to Dr. Langstraat from 5 drug and device companies from 2018 to 2025. Education make up the largest share, 68% of the total. Intuitive Surgical, Inc. paid the most, $5,654.

Dr. Langstraat graduated from University Of Minnesota Medical School in 2003. Dr. Langstraat is a member of American College of Obstetricians and Gynecologists, ACS and Society of Gynecologic Oncologists.

Dr. Langstraat is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.